{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:05:53Z","timestamp":1790366753637,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,9,25]],"date-time":"2027-09-25T00:00:00Z","timestamp":1821830400000},"content-version":"am","delay-in-days":389,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jacl.2026.07.035","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:12:34Z","timestamp":1785539554000},"page":"2056-2061","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Discordance between remnant cholesterol and small dense LDL cholesterol obscures interpretation of the results of the PROMINENT trial"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0896-8070","authenticated-orcid":false,"given":"Katsuyuki","family":"Nakajima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2026.07.035_bib1","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1056\/NEJMoa2210645","article-title":"Triglyceride lowering with pemafibrate to reduce cardiovascular risk","volume":"387","author":"Pradhan","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2026.07.035_bib2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ahj.2018.09.011","article-title":"Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients With Diabetes (PROMINENT) study","volume":"206","author":"Pradhan","year":"2018","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.jacl.2026.07.035_bib3","first-page":"556","article-title":"Pemafibrate and lipoprotein outcomes","volume":"147","author":"Sacks","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2026.07.035_bib4","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0140-6736(14)61177-6","article-title":"Triglycerides and cardiovascular disease","volume":"384","author":"Nordestgaard","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2026.07.035_bib5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jacc.2012.08.1026","article-title":"Remnant cholesterol as a causal risk factor","volume":"61","author":"Varbo","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2026.07.035_bib6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/ATVBAHA.113.302401","article-title":"New automated assay of small dense low-density lipoprotein colesterol identifies risk of coronary heart disease: the Multi-hic Study of Atherosclerosis","volume":"34","author":"Tsai","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2026.07.035_bib7","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/ATVBAHA.114.303284","article-title":"Small dense LDL and CVD risk","volume":"34","author":"Hoogeveen","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2026.07.035_bib8","first-page":"1485","article-title":"Kinetic analysis of lipoproteins","volume":"40","author":"Hellerstein","year":"1999","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2026.07.035_bib9","first-page":"212","article-title":"Lipoprotein kinetics and particle remodeling","volume":"56","author":"Packard","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2026.07.035_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0009-8981(93)90062-9","article-title":"Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gel","volume":"223","author":"Nakajima","year":"1993","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jacl.2026.07.035_bib11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cca.2005.12.013","article-title":"The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma","volume":"367","author":"Nakajima","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jacl.2026.07.035_bib12","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1161\/01.CIR.99.22.2858","article-title":"Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease","volume":"99","author":"Kugiyama","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2026.07.035_bib13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0021-9150(00)00484-6","article-title":"Remnant-like particle (RLP) cholesterol is an independent cardiovascular risk factor in women: results from the Framingham Heart Study","volume":"154","author":"McNamara","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.07.035_bib14","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1172\/JCI86610","article-title":"ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL receptor family pathways","volume":"126","author":"Gordts","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2026.07.035_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-2275(20)33334-4","article-title":"Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E","volume":"40","author":"Mahley","year":"1999","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2026.07.035_bib16","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0022-2275(20)36957-1","article-title":"Plasma CETP and lipid metabolism","volume":"34","author":"Tall","year":"1993","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2026.07.035_bib17","first-page":"146","article-title":"Hepatic lipase and lipoprotein remodeling","volume":"38","author":"Jansen","year":"1997","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2026.07.035_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1373\/clinchem.2010.149559","article-title":"Development of a homogeneous assay for measurement of small dense LDL cholesterol","volume":"57","author":"Ito","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2026.07.035_bib19","first-page":"147","article-title":"Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein","volume":"14","author":"Packard","year":"2003","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2026.07.035_bib20","first-page":"112","article-title":"Lipoprotein lipase biology","volume":"60","author":"Young","year":"2019","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2026.07.035_bib21","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bbalip.2014.03.013","article-title":"Physiological regulation of lipoprotein lipase","volume":"1841","author":"Kersten","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jacl.2026.07.035_bib22","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1194\/jlr.R800090-JLR200","article-title":"ApoB metabolism","volume":"50","author":"Ginsberg","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2026.07.035_bib23","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1001\/jama.1988.03410130125037","article-title":"Low-density lipoprotein subclass patterns","volume":"260","author":"Austin","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2026.07.035_bib24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/MOL.0b013e32833b7756","article-title":"Lipoprotein subfractions and cardiovascular risk","volume":"21","author":"Krauss","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2026.07.035_bib25","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1253\/circj.CJ-24-0770","article-title":"High level of estimated small dense low-density lipoprotein cholesterol as an independent risk factor for the development of ischemic heart disease regardless of low-density lipoprotein cholesterol level: a 10-year cohort study","volume":"89","author":"Endo","year":"2025","journal-title":"Circ J"},{"key":"10.1016\/j.jacl.2026.07.035_bib26","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019140","article-title":"Small dense low-density lipoprotein cholesterol is the most atherogenic lipoprotein parameter in the prospective Framingham Offspring Study","volume":"10","author":"Ikezaki","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacl.2026.07.035_bib27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCOUTCOMES.110.959247","article-title":"A meta-analysis of low-density lipoprotein cholesterol, non\u2013high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk","volume":"4","author":"Sniderman","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacl.2026.07.035_bib28","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","article-title":"Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management","volume":"32","author":"Chapman","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2026.07.035_bib29","first-page":"292","article-title":"Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein","volume":"30","author":"Packard","year":"2019","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2026.07.035_bib30","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jamacardio.2019.3780","article-title":"Apolipoprotein B particles and cardiovascular disease: a narrative review","volume":"4","author":"Sniderman","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacl.2026.07.035_bib31","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1093\/eurheartj\/ehab293","article-title":"Directly measured vs. calculated remnant cholesterol identifies additional overlooked individuals in the general population at higher risk of myocardial infarction","volume":"42","author":"Varbo","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2026.07.035_bib32","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jacl.2025.08.014","article-title":"Non-HDL and LDL cholesterol, but not calculated remnant cholesterol, are associated with subclinical atherosclerosis","volume":"19","author":"Mickelsson","year":"2025","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2026.07.035_bib33","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2026.07.035_bib34","first-page":"557","article-title":"TRL metabolism","volume":"17","author":"Bor\u00e9n","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacl.2026.07.035_bib35","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1194\/jlr.R800090-JLR200","article-title":"ApoB metabolism","volume":"50","author":"Ginsberg","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2026.07.035_bib36","first-page":"193","article-title":"ApoB and non-HDL cholesterol","volume":"131","author":"Sniderman","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2026.07.035_bib37","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"LDL and apoB causality","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426004642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426004642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:58:02Z","timestamp":1790366282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287426004642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1933287426004642"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2026.07.035","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discordance between remnant cholesterol and small dense LDL cholesterol obscures interpretation of the results of the PROMINENT trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2026.07.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 National Lipid Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}